TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ErGe BioTech AB
Closing information (x1000 DKK)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover |
939
|
944
|
990 |
Financial expenses |
1
![]() |
1
|
0 |
Earnings before taxes |
333
|
329
|
348 |
EBITDA |
334
|
330
|
348 |
Total assets |
1,206
|
1,079
|
891 |
Current assets |
530
|
338
|
248 |
Current liabilities |
109
|
165
|
212 |
Equity capital |
1,014
|
827
|
649 |
- share capital |
33
|
36
|
37 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency |
84.1%
|
76.6%
|
72.8% |
Turnover per employee |
939
|
472
|
495 |
Profit as a percentage of turnover |
35.5%
|
34.9%
|
35.2% |
Return on assets (ROA) |
27.7%
|
30.6%
|
39.1% |
Current ratio |
486.2%
|
204.8%
|
117.0% |
Return on equity (ROE) |
32.8%
|
39.8%
|
53.6% |
Change turnover |
78
|
-32
|
31 |
Change turnover % |
9%
|
-3%
|
3% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.